Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
211M
-
Number of holders
-
142
-
Total 13F shares, excl. options
-
73.7M
-
Shares change
-
+17.2M
-
Total reported value, excl. options
-
$2.3B
-
Value change
-
+$549M
-
Put/Call ratio
-
1
-
Number of buys
-
108
-
Number of sells
-
-31
-
Price
-
$31.21
Significant Holders of INSMED Inc - Common Stock, par value $0.01 per share (INSM) as of Q3 2017
178 filings reported holding INSM - INSMED Inc - Common Stock, par value $0.01 per share as of Q3 2017.
INSMED Inc - Common Stock, par value $0.01 per share (INSM) has 142 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 73.7M shares
of 211M outstanding shares and own 34.95% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (12.9M shares), FMR LLC (11.5M shares), BlackRock Inc. (7.01M shares), Palo Alto Investors, LLC (6.17M shares), VANGUARD GROUP INC (4.67M shares), JANUS HENDERSON GROUP PLC (3.96M shares), Redmile Group, LLC (1.99M shares), ORBIMED ADVISORS LLC (1.88M shares), STATE STREET CORP (1.77M shares), and LORD, ABBETT & CO. LLC (1.51M shares).
This table shows the top 142 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.